In focus
Latest feed
ELVN Shares Poised for Best Weekly Gain Since March Amid FDA Development Pathway News
Unpacking Tomorrow's Cancer Fight: Key Insights from AACR 2026
The FDA's Quiet Retreat: Fewer Public Debates Amid Rising Controversy
A Digital Doctor's Dilemma: Why ChatGPT's Medical Advice Is Falling Short in Emergencies
